Inhibrx Q2 EPS $(1.08) Down From $(0.97) YoY, Sales $30.00K Down From $711.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Inhibrx (NASDAQ:INBX) reported Q2 losses of $(1.08) per share, a 11.34% decrease YoY. The company's sales also decreased by 95.78% to $30.00K from $711.00K YoY.
August 07, 2023 | 8:21 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Inhibrx reported a YoY decrease in Q2 earnings and sales, which could negatively impact its stock price.
Inhibrx's reported decrease in Q2 earnings and sales indicates a potential negative impact on its financial performance, which could lead to a decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100